Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
4936	Seperate Operating Division Would this division be spun-off to current shareho	ALL	-	7/21/1998
4935	Fiscal Q4 Financial Analysis 1) Quarter-over-quarter, R&D increased 93.2%	ALL	-	7/21/1998
4934	Maybe I'm a bit naive, but I think that today's results year over year	Intel Trader	-	7/21/1998
4933	Sounds to me like AGPH is creating a tracking stock for the oncology division.	Vector1	-	7/21/1998
4932	My guess is there will be another stock traded under a separate symbol. It appe	sam	-	7/21/1998
4931	I hope this wasn't the big news. This wouldn't cover R&D costs	Steve Fancy	-	7/21/1998
4930	Any idea what a "separate divisional stock" means? Does that imply th	Izzy	-	7/21/1998
4929	fyi, just continuing to throw stuff against the wall in case any one's inte	Peter Singleton	-	7/21/1998
4928	Agouron Reports 1998 Net Income; Announces Intention to Create Separate Oncolog	kfdkfd	-	7/21/1998
4927	Hope you're right Oliver. Obviously Doug Lind was told by AGPH that the	Steve Fancy	-	7/21/1998
4926	more stuff to chew on ... BARS estimates as of 4/15, no idea what they were est	Peter Singleton	-	7/21/1998
4925	FOR RELEASE Monday, July 20, 1998 Greg Folkers (301) 496-2263 gfolkers@nih.g	Oliver & Co	-	7/21/1998
4924	"Prior to such license fees and related costs, annual fiscal income for Q4	margie	-	7/21/1998
4923	also fyi, PW's 5/18 report, originally posted here. Elsie W had US sales e	Peter Singleton	-	7/21/1998
4922	Yep, initially doesn't look good. Let's hope the conference call is	Steve Fancy	-	7/21/1998
4921	<<Agouron Pharmaceuticals, Inc. AGPH today announced fiscal 1998 net inco	Oliver & Co	-	7/21/1998
4920	pulled the following ML estimates (I thought from 5/98, but their Viracept sale	Peter Singleton	-	7/21/1998
4919	Agouron Pharmaceuticals (AGPH) 28 3/4 -3/4: company reports a Q4 loss of $0.29	Steve Fancy	-	7/21/1998
4918	Agouron Reports 1998 Net Income; Announces Intention to Create Separate Oncolog	Oliver & Co	-	7/21/1998
4917	------------------------------------------------------------------------------	Oliver & Co	-	7/21/1998
4916	$04:04 PM RTR AGOURON Q4 DIL SHR LOSS $0.29 VS LOSS $0.38 07/06/98 RTR RESEARC	Oliver & Co	-	7/21/1998
4915	Conference Call Telephone Number Does anyone have the conference call number.	ALL	-	7/21/1998
4914	fyi, on the status of the GARFT program (AG2034 et al). AG2034 is wrapping up	Peter Singleton	-	7/21/1998
4913	The market is looking for about $100m in Viracept rev. I think they will beat	Vector1	-	7/21/1998
4912	Earnings will be in line with 'guidance'. I'd expect a positive cc	Intel Trader	-	7/21/1998

Go to reply# or date (mm/dd/yy):